Home/Filings/4/0000874716-24-000035
4//SEC Filing

FENNELL GEORGE 4

Accession 0000874716-24-000035

CIK 0000874716other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:55 PM ET

Size

28.8 KB

Accession

0000874716-24-000035

Insider Transaction Report

Form 4
Period: 2024-02-14
FENNELL GEORGE
CORPORATE VICE PRESIDENT
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-14+976,917 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+526,969 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+1086,820 total
  • Exercise/Conversion

    Common Stock

    2024-02-14+577,082 total
  • Award

    Incentive Stock Option (right-to-buy)

    2024-02-14+178178 total
    Exercise: $560.56Exp: 2034-02-13Common Stock (178 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-145251 total
    Common Stock (52 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-1457169 total
    Common Stock (57 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14970 total
    Common Stock (97 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-14+567,025 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-141080 total
    Common Stock (108 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-1456111 total
    Common Stock (56 underlying)
  • Tax Payment

    Common Stock

    2024-02-14$560.56/sh162$90,8116,920 total
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2024-02-14+2,4082,408 total
    Exercise: $560.56Exp: 2034-02-13Common Stock (2,408 underlying)
  • Award

    Restricted Stock Unit

    2024-02-14+557557 total
    Common Stock (557 underlying)
Footnotes (8)
  • [F1]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
  • [F3]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
  • [F4]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in five annual installments beginning on February 14, 2020.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments beginning on February 14, 2021.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four annual installments beginning on February 14, 2022.
  • [F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning ion February 14, 2023.
  • [F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2024.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001521861

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:55 PM ET
Size
28.8 KB